The ABL tyrosine kinase is activated in the BCR-ABL fusion protein and plays a central role in the pathogenesis of CML and Ph+ B-ALL [2]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.